67868-73-9

Usage

Uses

Used in Pharmaceutical Industry:
4-BROMO-2-METHOXYTOLUENE is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new medications and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 4-BROMO-2-METHOXYTOLUENE serves as a key intermediate in the production of agrochemicals, aiding in the creation of compounds that protect crops and enhance agricultural productivity.
Used in Fragrance Industry:
4-BROMO-2-METHOXYTOLUENE is utilized as a component in the synthesis of fragrance ingredients, leveraging its strong aromatic properties to contribute to the creation of various scent profiles in perfumes, cosmetics, and other fragranced products.
As an intermediate in organic compound manufacturing, 4-BROMO-2-METHOXYTOLUENE plays a crucial role in the chemical industry, enabling the production of a wide range of organic compounds for diverse applications. It is handled and stored following standard chemical safety protocols to ensure safe and effective use.

Upstream product

• 7151-68-0 3-methoxy-p-toluic acid 
• 87808-44-4 3-methoxy-4-methylbenzoyl chloride 
• 36138-76-8 5-bromo-2-methylphenol 
• 74-88-4 methyl iodide 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 7151-68-0 3-methoxy-p-toluic acid 
• 138822-98-7 N-(2,2-Dimethyl-2H-chromen-7-yl)-N-(3-methoxy-4-methyl-phenyl)-acetamide 
• 138842-71-4 (2,2-Dimethyl-2H-chromen-7-yl)-(3-methoxy-4-methyl-phenyl)-amine 
• 67868-78-4 4-Brom-o-anisaldehyd-diethylacetal 
• 60504-65-6 5-Dodecyl-2-methylanisol 
• 60488-51-9 5-Dodecyl-2-methyl-4-nitroanisol 
• 60488-49-5 Acetic acid 2-dodecyl-4-methoxy-5-methyl-phenyl ester 
• 60488-52-0 4-Amino-5-dodecyl-2-methylanisol 
• 113706-59-5 2-(3-methoxy-4-methylphenyl)-6-methylhept-5-en-2-ol 
• 59684-62-7 Xanthorrhizol 
• 51814-28-9 1-(3-methoxy-4-methylphenyl)-2-propanone 
• 769140-74-1 (±)-3β,12-dihydroxy-13-methylpodocarpane-8,11,13-triene 
• 858523-37-2 2-(4-bromo-2-methoxyphenyl)acetonitrile 
• 854778-42-0 4-bromo-1-(bromomethyl)-2-methoxybenzene 

Relevant academic research and scientific papers

Active Molybdenum-Based Anode for Dehydrogenative Coupling Reactions

A new and powerful active anode system that can be operated in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) has been discovered. In HFIP the molybdenum anode forms a compact, conductive, and electroactive layer of higher-valent molybdenum species. This system can replace powerful but stoichiometrically required MoV reagents for the dehydrogenative coupling of aryls. This electrolytic reaction is more sustainable and allows the conversion of a broad scope of activated arenes.

TRIAZOLONE COMPOUNDS AND USES THEREOF

The invention disclosed herein is directed to compounds of Formula I [Formula should be inserted here] and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leuke

A concise total synthesis of the purported structure of flossonol

We report the first total synthesis of flossonol in only five steps and of one of its isomers in seven steps using a radical addition/cyclization sequence as the key step. Comparison of our spectroscopic data with those of the literature indicates a misas

TRIAZOLONE COMPOUNDS AND USES THEREOF

The invention disclosed herein is directed to compounds of Formula (I) and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula (I), or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist. The compounds and pharmaceutical compositions of the invention are also useful in the treatment of viral infections, such as HCV infections and HIV infections. The invention disclosed herein is also directed to a methods of preventing the onset of and/or recurrence of acute and chronic myeloid leukemia, as well as other cancers, comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist.

A short synthesis of bisabolane sesquiterpenes

A facile total synthesis of three members of the bisabolane sesquiterpene family, namely (±)-curcumene, (±)-xanthorrhizol and (±)-curcuhydroquinone had been achieved in high overall yield. The synthesis used bromobenzene derivatives as starting materials.

Antithrombotic agents

This application relates to novel compounds of formula (I) (and their pharmaceutically acceptable salts), as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula (I), and

Iminodimethylene di-tert-alkylophenones and phenols

Substituted-iminodimethylene-di-tert-alkylophenones, e.g., 4", 4"'-methyliminodimethylene-dipivalophenone, are prepared by treating a corresponding α-halo-p-tert-alkanoyl toluene with a substituted amine. The phenylcarbinols are prepared from the corresponding phenones and both the phenones and the phenylcarbinols are useful as hypolipidemic agents.